Luca Gobbi,Georg Jaeschke,Olivier Roche,Rosa Maria Rodriguez Sarmiento,Lucinda Steward
申请号：
US13280523
公开号：
US20120040972A1
申请日:
2011.10.25
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to compounds of the formula (I)wherein R1, R2, X and n are as defined in the specification as dual modulators of the serotonin 5-HT2a and dopamine D3 receptors, their manufacture, pharmaceutical compositions containing them and their use for the treatment of psychotic disorders, as well as other diseases such as depression and anxiety, drug dependence, dementias and memory impairment.
